Scientists have reported encouraging early tests of a gene therapy strategy against Angelman syndrome, a neurodevelopmental disorder that features poor muscle control and balance, hard-to-treat epilepsy, and intellectual disabilities.
from Top Health News -- ScienceDaily https://ift.tt/3En93CT
Post a Comment